Norway Gene Synthesis (research Use) Market Size & Outlook

The gene synthesis (research use) market in Norway is expected to reach a projected revenue of US$ 12.0 million by 2030. A compound annual growth rate of 12% is expected of Norway gene synthesis (research use) market from 2023 to 2030.
Revenue, 2022 (US$M)
$4.8
Forecast, 2030 (US$M)
$12.0
CAGR, 2023 - 2030
12%
Report Coverage
Norway

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Norway gene synthesis (research use) market, 2018-2030 (US$M)

Norway gene synthesis (research use) market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Norway gene synthesis (research use) market highlights

  • The Norway gene synthesis (research use) market generated a revenue of USD 4.8 million in 2022 and is expected to reach USD 12.0 million by 2030.
  • The Norway market is expected to grow at a CAGR of 12% from 2023 to 2030.
  • In terms of segment, solid-phase synthesis was the largest revenue generating method in 2022.
  • PCR-based Enzyme Synthesis is the most lucrative method segment registering the fastest growth during the forecast period.


Gene synthesis (research use) market data book summary

Market revenue in 2022USD 4.8 million
Market revenue in 2030USD 12.0 million
Growth rate12% (CAGR from 2022 to 2030)
Largest segmentSolid-phase synthesis
Fastest growing segmentPCR-based Enzyme Synthesis
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSolid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis
Key market players worldwideGenScript ProBio, Azenta Inc, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, NanHua Bio-medicine, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies, ProMab Biotechnologies Inc


Other key industry trends

  • In terms of revenue, Norway accounted for 0.3% of the global gene synthesis (research use) market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, France gene synthesis (research use) market is projected to lead the regional market in terms of revenue in 2030.
  • Netherlands is the fastest growing regional market in Europe and is projected to reach USD 98.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gene Synthesis (Research Use) Market Companies

Name Profile # Employees HQ Website
ProMab Biotechnologies Inc View profile 51-100 Richmond, California, United States, North America http://www.promab.com
NanHua Bio-medicine View profile 251-500 Tianxin, Hunan, China, Asia http://www.nhbiogroup.com
Integrated DNA Technologies View profile 501-1000 Coralville, Iowa, United States, North America http://idtdna.com
Biomatik Corporation View profile 11-50 Cambridge, Ontario, Canada, North America http://www.biomatik.com
ProteoGenix View profile 11-50 Costa Mesa, California, United States, North America https://www.proteogenix.science
Origene Technologies View profile 501-1000 Rockville, Maryland, United States, North America http://www.origene.com
Twist Bioscience Corp View profile 919 681 Gateway Boulevard, South San Francisco, CA, United States, 94080 https://www.twistbioscience.com
GenScript ProBio View profile 1001-5000 Nanjing, Jiangsu, China, Asia https://www.genscriptprobio.cn
Azenta Inc View profile 3400 200 Summit Drive, 6th Floor, Burlington, MA, United States, 01803 https://www.azenta.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Norway gene synthesis (research use) market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis (research use) market will help companies and investors design strategic landscapes.


Solid-phase synthesis was the largest segment with a revenue share of 37.5% in 2022. Horizon Databook has segmented the Norway gene synthesis (research use) market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Norway gene synthesis (research use) market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Norway gene synthesis (research use) market databook

  • Our clientele includes a mix of gene synthesis (research use) market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Norway gene synthesis (research use) market, including forecasts for subscribers. This country databook contains high-level insights into Norway gene synthesis (research use) market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Norway gene synthesis research use market report size, by method, 2018-2030 (US$M)

Norway Gene Synthesis (Research Use) Market Share, 2022 & 2030 (US$M)

Norway gene synthesis research use market report size, by method, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online